Insmed (INSM) PT Raised to $245 at H.C. Wainwright

March 26, 2026 11:16 AM

H.C. Wainwright analyst Andrew Fein raised the price target on Insmed (NASDAQ: INSM) to $245.00 (from $230.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found